Tocilizumab in COVID-19 therapy: who benefits, and how? Neumann AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al. Lancet 2021;398:299-300.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neumann AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al. Tocilizumab in COVID-19 therapy: who benefits, and how? Lancet 2021;398:299-300.
PMID: 34303430